Results for tag: "Vectibix"

Vectibix (panitumumab) is a monoclonal antibody used to treat metastatic colorectal cancer. It is a targeted therapy that works by blocking the action of a protein called epidermal growth factor receptor (EGFR). This protein is found on the surface of some cancer cells and helps them to grow and spread. Vectibix is used in combination with chemotherapy to treat metastatic colorectal cancer that has not responded to other treatments. It is also used to treat colorectal cancer that has spread to other parts of the body. The Vectibix market is a subset of the larger colon cancer drugs market. It is a competitive market with a number of different drugs available to treat metastatic colorectal cancer. The market is driven by the increasing prevalence of colorectal cancer, as well as advances in targeted therapies. Some of the companies in the Vectibix market include Amgen, Merck, Pfizer, and Roche. Show Less Read more